Close

Ratings by Leerink Partners (Joseph P. Schwartz)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/22/2024 Applied Therapeutics APLT New Coverage Outperform
(N/A)
5.13
(5.26)
2.53% Details
12/19/2023 WAVE Life Sciences WVE Upgrade Outperform
(Market Perform)
4.49
(6.48)
44.32% Details
12/15/2023 Reneo Pharmaceuticals RPHM Downgrade Market Perform
(Outperform)
7.75
(1.70)
-78.06% Details
8/18/2023 Selecta Biosciences SELB Downgrade Market Perform
(Outperform)
1.12
(0.88)
-21.43% Details
6/12/2023 Reata Pharmaceuticals RETA Upgrade Outperform
(Market Perform)
93.80
(172.36)
83.75% Details
3/17/2023 PTC Therapeutics PTCT New Coverage Market Perform
(N/A)
48.10
(36.90)
-23.28% Details
12/13/2022 Horizon Therapeutics HZNP Downgrade Market Perform
(Outperform)
112.36
(116.30)
3.51% Details
10/20/2022 Travere Therapeutics TVTX Maintain Outperform
(N/A)
 
 
  Details
9/12/2022 Merck MRK Maintain Outperform
(N/A)
 
 
  Details
8/4/2022 Travere Therapeutics TVTX Maintain Outperform
(N/A)
 
 
  Details
8/4/2022 Horizon Therapeutics HZNP Upgrade Outperform
(Market Perform)
66.96
(116.30)
73.69% Details
6/6/2022 Merck MRK New Coverage Outperform
(N/A)
89.91
(129.37)
43.89% Details
6/6/2022 Horizon Therapeutics HZNP New Coverage Market Perform
(N/A)
91.29
(116.30)
27.4% Details
6/6/2022 Selecta Biosciences SELB New Coverage Outperform
(N/A)
0.88
(0.88)
0% Details
5/31/2022 PepGen Inc. PEPG New Coverage Outperform
(N/A)
10.88
(17.48)
60.66% Details
5/9/2022 Fulcrum Therapeutics FULC Maintain Outperform
(N/A)
 
 
  Details
12/15/2021 Travere Therapeutics TVTX Maintain Outperform
(N/A)
 
 
  Details
12/9/2021 Reata Pharmaceuticals RETA Downgrade Market Perform
(Outperform)
54.42
(172.36)
216.72% Details
11/5/2021 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
8/16/2021 Travere Therapeutics TVTX Maintain Outperform
(N/A)
 
 
  Details
5/4/2021 Reneo Pharmaceuticals RPHM New Coverage Outperform
(N/A)
14.50
(1.70)
-88.28% Details
10/26/2020 Crinetics CRNX Maintain Outperform
(N/A)
 
 
  Details
8/6/2020 Insmed INSM Maintain Outperform
(N/A)
 
 
  Details
10/15/2019 Reata Pharmaceuticals RETA Maintain Outperform
(N/A)
 
 
  Details
11/6/2018 Spark Therapeutics ONCE Maintain Market Perform
(N/A)
 
 
  Details